Read Our New mRNA Synthesis Whitepaper

Learn the seven most critical considerations when sourcing mRNA for vaccine or therapy development; including plasmid DNA integrity, polyA tail consistency, capping options, uridine modification, LNP packaging, manufacturing workflow, QA/QC, and more.

Cell & Gene Therapy Market Growth Infographic
Please enter a valid first name.
Please enter a valid last name.
Please enter a valid email address.
Please enter a valid institution/company.
Please select a valid country.
Please enter a valid postal code.
Are you currently working with mRNA?

Whitepaper Highlights

  • Effects of plasmid DNA integrity on mRNA quality
  • Production strategies for improved PolyA tail consistency
  • mRNA capping options for different cell types
  • Importance of uridine modification
  • LNP packaging strategies for improved mRNA delivery
  • Benefits of integrated manufacturing workflow & customizable QA/QC options

REQUEST A QUOTE

feedback

Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*